Multi-cycle cisplatin treatment alters spermatogonial functional stem cell behavior and niche
A typical clinical cis-diamminedichloroplatinum (II) (cisplatin) dosing regimen consists of repeated cycles of five to seven daily low dose treatments followed by a one to two week recovery period. While effective, this dosing structure results in a prolonged, and sometimes permanent, infertility in...
Main Author: | Harman, James Gregory |
---|---|
Format: | Others |
Language: | en_US |
Published: |
2014
|
Subjects: | |
Online Access: | http://hdl.handle.net/2152/23101 |
Similar Items
-
Identification of Niche Conditions Supporting Short-term Culture of Spermatogonial Stem Cells Derived from Porcine Neonatal Testis
by: Min Hee Park, et al.
Published: (2014-09-01) -
Possible use of spermatogonial stem cells in the treatment of male infertility
by: N. N. Skaletsky, et al.
Published: (2020-02-01) -
Identification of EOMES-expressing spermatogonial stem cells and their regulation by PLZF
by: Manju Sharma, et al.
Published: (2019-05-01) -
Spermatogonial Stem Cell Self - renewal and Differentiation
by: Li-Huan Cao, et al.
Published: (2017-01-01) -
Melatonin improves spermatogonial stem cells transplantation efficiency in azoospermic mice
by: Mohammadreza Gholami, et al.
Published: (2014-02-01)